Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating the efficacy and safety of HGP0412 and HIP1402 in patients with benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• HGP0412
• HIP1402

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Benign Prostate Hyperplasia | Phase 3 | Status: COMPLETED